Stay updated on AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer's revision number changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T03:55:36.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    0.8%
    Check dated 2026-10-25T04:39:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T03:51:02.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T08:14:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Adds a new revision entry v3.7.0 to the study history and removes the previous v3.6.6, representing an update to the record version in the history log.
    Difference
    0.1%
    Check dated 2026-09-20T03:11:13.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new revision v3.6.6 was added to the study record history, updating the page version from the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T00:35:19.000Z thumbnail image

Stay in the know with updates to AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.